Psychiatry and Neurology, Neurology · Athens, GA
NPI
1851576557
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1086 1/2 Baxter St
Athens, GA, 30606
Phone (706) 353-0606
Groups this clinician bills Medicare through
Medicare paid, 2024
$205K
20,982 services
Medicare patients, 2024
770
Average age 73
Drug cost, 2024
$1.5M
6,457 prescriptions
Company payments, 2025
$2,629
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Denise S Taylor was code J0585 (injection, onabotulinumtoxina, 1 unit), 16,630 times for 28 patients. In total Denise S Taylor billed 20,982 services in 48 codes, and Medicare paid $205K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 16,630 | 28 | $4.80 | $80K |
| 99214 Office E&M - Established | Office | 486 | 399 | $69.38 | $34K |
| 99205 Office E&M - New | Office | 148 | 148 | $130.89 | $19K |
| 99213 Office E&M - Established | Office | 107 | 99 | $53.75 | $5,751 |
| 99215 Office E&M - Established | Office | 70 | 70 | $108.39 | $7,587 |
| 99223 Hospital E&M - Initial | Facility | 60 | 60 | $114.68 | $6,881 |
| 99204 Office E&M - New | Office | 48 | 48 | $93.53 | $4,489 |
| 64615 Musculoskeletal | Office | 45 | 15 | $105.84 | $4,763 |
| 99233 Hospital E&M - Subsequent | Facility | 35 | 26 | $81.44 | $2,850 |
| 95874 Musculoskeletal | Office | 33 | 12 | $46.68 | $1,540 |
| 72141 MRI/MRA - Spine | Office | 20 | 20 | $121.39 | $2,428 |
| 95819 Neurologic | Office | 15 | 15 | $260.35 | $3,905 |
| 95816 Neurologic | Office | 13 | 13 | $245.93 | $3,197 |
| 95819 Neurologic | Facility | 12 | 12 | $35.07 | $421 |
By year: 2022 $196K for 13,004 services; 2023 $178K for 16,790 services; 2024 $205K for 20,982 services.
Medicare prescription drug claims, 2024
In 2024, the drug Denise S Taylor prescribed most often to Medicare patients was Memantine Hcl, with 468 prescriptions and refills. In total Denise S Taylor wrote 6,457 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 468 | 716 | 122 | $9,744 |
| Gabapentin Generic | 448 | 623 | 117 | $7,156 |
| Donepezil Hcl Generic | 359 | 624 | 98 | $2,460 |
| Levetiracetam Generic | 336 | 589 | 78 | $11K |
| Pregabalin Generic | 302 | 355 | 59 | $7,727 |
| Memantine Hcl Er Memantine Hcl | 249 | 499 | 64 | $27K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 209 | 406 | 55 | $5,795 |
| Lacosamide Generic | 207 | 223 | 25 | $16K |
| Lamotrigine Generic | 172 | 266 | 25 | $4,122 |
| Levetiracetam Er Levetiracetam | 164 | 300 | 35 | $9,515 |
| Clonazepam Generic | 131 | 145 | 18 | $897 |
| Amitriptyline Hcl Generic | 127 | 203 | 29 | $1,738 |
| Topiramate Generic | 120 | 232 | 27 | $5,913 |
| Mirtazapine Generic | 114 | 209 | 30 | $1,434 |
| Clobazam Generic | 111 | 127 | 16 | $9,134 |
Brand drugs: 726 claims; generic drugs: 5,695 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Denise S Taylor $2,629 ($2,629 in general payments such as food, travel and fees) from 32 companies. The largest payer was Abbvie Inc. with $303.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 36 | $303 |
| UCB, Inc. UCB.BR | 12 | $240 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $237 |
| LivaNova USA, Inc. LIVN | 2 | $229 |
| Teva Pharmaceuticals USA, Inc. TEVA | 7 | $156 |
| Argenx US, Inc. ARGX | 2 | $121 |
| ACADIA Pharmaceuticals Inc ACAD | 6 | $119 |
| TG Therapeutics, Inc. TGTX | 4 | $101 |
| Harmony Biosciences LLC HRMY | 4 | $92.62 |
| Ge Healthcare GEHC | 2 | $81.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.